Literature DB >> 21620567

Contribution of afferent pathways to nerve injury-induced spontaneous pain and evoked hypersensitivity.

Tamara King1, Chaoling Qu, Alec Okun, Ramon Mercado, Jiyang Ren, Triza Brion, Josephine Lai, Frank Porreca.   

Abstract

A predominant complaint in patients with neuropathic pain is spontaneous pain, often described as burning. Recent studies have demonstrated that negative reinforcement can be used to unmask spontaneous neuropathic pain, allowing for mechanistic investigations. Here, ascending pathways that might contribute to evoked and spontaneous components of an experimental neuropathic pain model were explored. Desensitization of TRPV1-positive fibers with systemic resiniferatoxin (RTX) abolished spinal nerve ligation (SNL) injury-induced thermal hypersensitivity and spontaneous pain, but had no effect on tactile hypersensitivity. Ablation of spinal NK-1 receptor-expressing neurons blocked SNL-induced thermal and tactile hypersensitivity as well as spontaneous pain. After nerve injury, upregulation of neuropeptide Y (NPY) is observed almost exclusively in large-diameter fibers, and inactivation of the brainstem target of these fibers in the nucleus gracilis prevents tactile but not thermal hypersensitivity. Blockade of NPY signaling within the nucleus gracilis failed to block SNL-induced spontaneous pain or thermal hyperalgesia while fully reversing tactile hypersensitivity. Moreover, microinjection of NPY into nucleus gracilis produced robust tactile hypersensitivity, but failed to induce conditioned place aversion. These data suggest that spontaneous neuropathic pain and thermal hyperalgesia are mediated by TRPV1-positive fibers and spinal NK-1-positive ascending projections. In contrast, the large-diameter dorsal column projection can mediate nerve injury-induced tactile hypersensitivity, but does not contribute to spontaneous pain. Because inhibition of tactile hypersensitivity can be achieved either by spinal manipulations or by inactivation of signaling within the nucleus gracilis, the enhanced paw withdrawal response evoked by tactile stimulation does not necessarily reflect allodynia.
Copyright © 2011 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21620567      PMCID: PMC3306802          DOI: 10.1016/j.pain.2011.04.020

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  40 in total

1.  Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor.

Authors:  F Porreca; S E Burgess; L R Gardell; T W Vanderah; T P Malan; M H Ossipov; D A Lappi; J Lai
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y.

Authors:  Michael H Ossipov; En-Tan Zhang; Cristina Carvajal; Luis Gardell; Remi Quirion; Yvan Dumont; Josephine Lai; Frank Porreca
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

3.  Focal inhibitory interneuron loss and principal cell hyperexcitability in the rat hippocampus after microinjection of a neurotoxic conjugate of saporin and a peptidase-resistant analog of Substance P.

Authors:  J L Martin; R S Sloviter
Journal:  J Comp Neurol       Date:  2001-07-23       Impact factor: 3.215

4.  Nerve injury-induced tactile allodynia is mediated via ascending spinal dorsal column projections.

Authors:  H Sun; K Ren; C M Zhong; M H Ossipov; T P Malan; J Lai; F Porreca
Journal:  Pain       Date:  2001-02-01       Impact factor: 6.961

5.  Capsaicin evoked pain and allodynia in post-herpetic neuralgia.

Authors:  Karin L Petersen; Howard L Fields; Jannick Brennum; Paola Sandroni; Michael C Rowbotham
Journal:  Pain       Date:  2000-11       Impact factor: 6.961

6.  Neurokinin 1 receptor expression by neurons in laminae I, III and IV of the rat spinal dorsal horn that project to the brainstem.

Authors:  A J Todd; M M McGill; S A Shehab
Journal:  Eur J Neurosci       Date:  2000-02       Impact factor: 3.386

7.  Transmission of chronic nociception by spinal neurons expressing the substance P receptor.

Authors:  M L Nichols; B J Allen; S D Rogers; J R Ghilardi; P Honore; N M Luger; M P Finke; J Li; D A Lappi; D A Simone; P W Mantyh
Journal:  Science       Date:  1999-11-19       Impact factor: 47.728

8.  Projection neurons in lamina I of rat spinal cord with the neurokinin 1 receptor are selectively innervated by substance p-containing afferents and respond to noxious stimulation.

Authors:  Andrew J Todd; Zita Puskar; Rosemary C Spike; Catriona Hughes; Christine Watt; Lisa Forrest
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

9.  Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons.

Authors:  P Honore; S D Rogers; M J Schwei; J L Salak-Johnson; N M Luger; M C Sabino; D R Clohisy; P W Mantyh
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

10.  Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain.

Authors:  Shannon E Burgess; Luis R Gardell; Michael H Ossipov; T Philip Malan; Todd W Vanderah; Josephine Lai; Frank Porreca
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

View more
  39 in total

1.  Pain processing by spinal microcircuits: afferent combinatorics.

Authors:  Steven A Prescott; Stéphanie Ratté
Journal:  Curr Opin Neurobiol       Date:  2012-03-10       Impact factor: 6.627

Review 2.  Spinal Cord Stimulation for Pain Treatment After Spinal Cord Injury.

Authors:  Qian Huang; Wanru Duan; Eellan Sivanesan; Shuguang Liu; Fei Yang; Zhiyong Chen; Neil C Ford; Xueming Chen; Yun Guan
Journal:  Neurosci Bull       Date:  2018-12-17       Impact factor: 5.203

Review 3.  ThermoTRPs and Pain.

Authors:  Robyn J Laing; Ajay Dhaka
Journal:  Neuroscientist       Date:  2015-01-21       Impact factor: 7.519

Review 4.  Pros and Cons of Clinically Relevant Methods to Assess Pain in Rodents.

Authors:  Anke Tappe-Theodor; Tamara King; Michael M Morgan
Journal:  Neurosci Biobehav Rev       Date:  2019-03-15       Impact factor: 8.989

Review 5.  Unravelling the mystery of capsaicin: a tool to understand and treat pain.

Authors:  Jessica O'Neill; Christina Brock; Anne Estrup Olesen; Trine Andresen; Matias Nilsson; Anthony H Dickenson
Journal:  Pharmacol Rev       Date:  2012-10       Impact factor: 25.468

6.  Descending facilitation maintains long-term spontaneous neuropathic pain.

Authors:  Ruizhong Wang; Tamara King; Milena De Felice; Wenhong Guo; Michael H Ossipov; Frank Porreca
Journal:  J Pain       Date:  2013-04-19       Impact factor: 5.820

7.  Spontaneous and Bite-Evoked Muscle Pain Are Mediated by a Common Nociceptive Pathway With Differential Contribution by TRPV1.

Authors:  Sheng Wang; Jongseuk Lim; John Joseph; Sen Wang; Feng Wei; Jin Y Ro; Man-Kyo Chung
Journal:  J Pain       Date:  2017-06-29       Impact factor: 5.820

8.  Mediation of Movement-Induced Breakthrough Cancer Pain by IB4-Binding Nociceptors in Rats.

Authors:  Joshua Havelin; Ian Imbert; Devki Sukhtankar; Bethany Remeniuk; Ian Pelletier; Jonathan Gentry; Alec Okun; Timothy Tiutan; Frank Porreca; Tamara E King
Journal:  J Neurosci       Date:  2017-04-24       Impact factor: 6.167

9.  Persistent hyperalgesia in the cisplatin-treated mouse as defined by threshold measures, the conditioned place preference paradigm, and changes in dorsal root ganglia activated transcription factor 3: the effects of gabapentin, ketorolac, and etanercept.

Authors:  Hue Jung Park; Jennifer A Stokes; Elaine Pirie; James Skahen; Yuri Shtaerman; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-12-07       Impact factor: 5.108

Review 10.  Evaluation of reward from pain relief.

Authors:  Edita Navratilova; Jennifer Yanhua Xie; Tamara King; Frank Porreca
Journal:  Ann N Y Acad Sci       Date:  2013-03-15       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.